Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension. Achievements and Perspectives
Hypertension, 09/03/09
Grassi G – The present review will focus on some major features of the "neuroadrenergic hypothesis of hypertension." In particular it will examine the mechanisms responsible for the adrenergic overdrive, the relationships between the sympathetic activation and the metabolic disarray of frequent detection in the hypertensive state, and the participation of neuroadrenergic factors at the development of the hypertension–related target organ damage.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 91%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Haemodynamic profile of young subjects with transient tinnitus
Audiological Medicine, 12/07/09
Long-Term Stability of Cardiovascular and Catecholamine Responses to Stress Tests. An 18-Year Follow-Up Study
Hypertension, 12/07/09
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Convertng Enzyme 2. Prevention of Angiotensin II–Dependent Hypertension
Hypertension, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


